ACCESSION: MSBNK-SMB_Measured-HSA014P0186000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 22
COMMENT: RAW_SPEC {'EL16-neg_3167': {'bp': 154966.0, 'sum': 494805.0}, 'EL19-neg_3178': {'bp': 134831.0, 'sum': 436980.0}, 'EL06-neg_3169': {'bp': 129740.0, 'sum': 432897.0}, 'EL02-neg_3204': {'bp': 118284.0, 'sum': 417975.0}, 'EL20-neg_3177': {'bp': 103382.0, 'sum': 360923.0}, 'EL09-neg_3174': {'bp': 92050.0, 'sum': 321729.0}, 'EL22-neg_3180': {'bp': 82445.0, 'sum': 338486.0}, 'EL05-neg_3176': {'bp': 81115.0, 'sum': 332978.0}, 'EL15-neg_3180': {'bp': 78225.0, 'sum': 292338.0}, 'EL04-neg_3154': {'bp': 71161.0, 'sum': 299323.0}, 'EL11-neg_3167': {'bp': 68005.0, 'sum': 282559.0}, 'EL23-neg_3174': {'bp': 64938.0, 'sum': 271666.0}, 'EL10-neg_3171': {'bp': 63470.0, 'sum': 274965.0}, 'EL08-neg_3168': {'bp': 54999.0, 'sum': 254540.0}, 'EL01-neg_3169': {'bp': 54837.0, 'sum': 235211.0}, 'EL03-neg_3172': {'bp': 52417.0, 'sum': 226883.0}, 'EL24-neg_3160': {'bp': 46424.0, 'sum': 219067.0}, 'Blanc3-neg_3142': {'bp': 46417.0, 'sum': 232273.0}, 'EL14-neg_3178': {'bp': 45199.0, 'sum': 220325.0}, 'EL17-neg_3177': {'bp': 44981.0, 'sum': 208231.0}, 'Blanc2-neg_3136': {'bp': 41643.0, 'sum': 215709.0}, 'EL07-neg_3172': {'bp': 39711.0, 'sum': 220496.0}}
COMMENT: RETENTION_TIME_STDEV 0.010
COMMENT: PRECURSOR_M/Z_RAW 186.112645
COMMENT: PRECURSOR_M/Z_STDEV 0.000085
COMMENT: PRECURSOR_IN_MS1 mz 186.113072; int 46.085; delta(ppm) 2.678449
COMMENT: PROPOSED_CHARGE_STATE -1; mz 187.116517; int 4.221; cor 0.949
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+FA-H; M+TFA-H; mz 254.101071; int 1.594; cor 0.806
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 2.661; C9H17NO3; [M-H]1; delta(ppm) -2.661389
COMMENT: PROPOSED_MF SevenGoldenRules 3.515; C8H15NO; [M+FA-H]1; delta(ppm) -3.514867
COMMENT: PROPOSED_MF MS-FINDER 3.344; C9H17NO3; [M-H]-; delta(ppm) -2.675699
COMMENT: PROPOSED_MF MS-FINDER 3.186; C8H15NO; [M+FA-H]-; delta(ppm) 169739.010704
COMMENT: PROPOSED_MF SIRIUS5_Sirius 26.673; C9H17NO3; [M-H]-; delta(ppm) -2.675699
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H17NO3; [M-H]-; delta(ppm) -2.675699
COMMENT: PROPOSED_MF SIRIUS6_Sirius 33.901; C8H15NO; [M+CH2O2-H]-; delta(ppm) 476005.004935
COMMENT: PROPOSED_MF SIRIUS6_Sirius 33.901; C9H17NO3; [M-H]-; delta(ppm) -2.675699
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.412; C6H13N4; [M+CH2O2-H]-; delta(ppm) 309862.030487
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.412; C7H15N4O2; [M-H]-; delta(ppm) 4.538551
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H17NO3; [M-H]-; delta(ppm) -2.675699
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.995; C8H15NO; [M+CH2O2-H]-; delta(ppm) 476005.004935
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.005; C6H13N4; [M+CH2O2-H]-; delta(ppm) 309862.030487
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.925; GUAHPAJOXVYFON-UHFFFAOYNA-N; [M-H]-; CC(N)C(=O)CCCCCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.699; CLKPVQZFNYXFCY-UHFFFAOYSA-N; [M-H]-; CC1(CC(C(N1O)(C)C)C(=O)O)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.515; CLZYHHJDMWJIKU-UHFFFAOYSA-N; [M-H]-; O=C(O)CCC(NC)C(=O)C(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.487; VBZVQWDDUOUQHA-UHFFFAOYSA-N; [M-H]-; NCC(=O)CCCCCCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.467; SRPNQDXRVRCTNK-UHFFFAOYSA-N; [M-H]-; CC(C)(C)C(=O)NCCCC(O)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.681; GUAHPAJOXVYFON-UHFFFAOYNA-N; [M-H]-; Polyethylene glycol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.219; RNFCYFVPNIXAHP-UHFFFAOYSA-N; [M-H]-; N-Heptanoylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.102; AGLLYYHKZWZSKX-VQZIKBDANA-N; [M-H]-; Hyacinthacine A3;(1R,2R,3R,5R,7aR)-1,2-Dihydroxy-3-hydroxymethyl-5-methylpyrrolizidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.066; RPALEGQGCGCFCX-FIWMUJSFSA-N; [M-H]-; (E)-2-Butenyl-4-methyl-threonine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.061; CYHOMWAPJJPNMW-INTDOSGANA-N; [M+FA-H]-; Pseudotropine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.056; SRPNQDXRVRCTNK-UHFFFAOYSA-N; [M-H]-; pivagabine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.056; VBZVQWDDUOUQHA-UHFFFAOYSA-N; [M-H]-; UNPD76707
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.047; UKWXGBZWYMGFTJ-MQWKRIRWSA-N; [M-H]-; (2S)-2-(1-hydroxybut-3-en-2-ylamino)-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.039; JKTAZDIARLXYPE-MQWKRIRWSA-N; [M-H]-; (2S)-2-(2-hydroxybut-3-enylamino)-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.998; CLZYHHJDMWJIKU-UHFFFAOYSA-N; [M-H]-; 6-methyl-4-(methylamino)-5-oxoheptanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.992; WEFZXWJJPHGTTN-UHFFFAOYNA-N; [M-H]-; methyl 5-(dimethylamino)-2-methyl-5-oxopentanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.988; CLKPVQZFNYXFCY-UHFFFAOYSA-N; [M-H]-; 1-hydroxy-2,2,5,5-tetramethylpyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.983; RAAWJSCIRLJCEG-UHFFFAOYSA-N; [M-H]-; 4-methylmorpholin-2-yl 2-methylpropanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.981; ADKXZIOQKHHDNQ-SVGMAFHSNA-N; [M+FA-H]-; (+)-Hygrine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.952; JEIZLWNUBXHADF-SVGMAFHSNA-N; [M+FA-H]-; (R)-Pelletierine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.944; NPDKTSLVWGFPQG-UHFFFAOYNA-N; [M-H]-; (3R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.848; FDOBDBWYWMTMKT-UHFFFAOYNA-N; [M+FA-H]-; Conhydrinone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.818; HHEXLXPVRAJVIS-FPLPWBNLSA-N; [M+FA-H]-; UNPD196130
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.808; BKWVNPXVPQOROM-MBPFSUDVNA-N; [M+FA-H]-; Physoperuvine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.778; UUTIAUFCXVFAOM-HJWRWDBZSA-N; [M+FA-H]-; UNPD131274
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.772; LOFDEIYZIAVXHE-YUMQZZPRSA-N; [M+FA-H]-; Trachelanthamidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.766; HINLFAQOKAHXOD-UHFFFAOYSA-N; [M+FA-H]-; 2-propan-2-ylpent-4-enamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.759; SMAUMNRVOPPBNC-JLDDOWRYNA-N; [M+FA-H]-; (+)-Physoperuvine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.738; XKJCOKCJVCRUCC-UHFFFAOYSA-N; [M+FA-H]-; 4-(tert-butylamino)but-3-en-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.731; FKJHJSJBXISMIR-UHFFFAOYSA-N; [M+FA-H]-; 1-(1-Pyrrolidinyl)-2-butanone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.731; IXYTUYCLJBLYKD-UHFFFAOYNA-N; [M+FA-H]-; 3-(1-Pyrrolidinyl)-2-butanone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.726; ACGZBRWTWOZSFU-UHFFFAOYSA-N; [M+FA-H]-; 4-(diethylamino)-2-butyn-1-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.715; OCHUGKAFISDSCN-UHFFFAOYSA-N; [M+FA-H]-; 6-methyl-5-(propan-2-yl)-3,4-dihydro-2H-oxazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.707; TZEMYNIWYNDOLG-JLDDOWRYNA-N; [M+FA-H]-; UNPD173371
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.679; VJPHAMJNGICSLT-UHFFFAOYSA-N; [M+FA-H]-; UNPD53487
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.655; JLFAFRJZNUBKDM-UHFFFAOYSA-N; [M+FA-H]-; 2,2,3,3-tetramethylcyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.651; PGMBNUMLNAJSJR-CFQLRCIDNA-N; [M+FA-H]-; UNPD24103
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.640; PGGCTNQYCZTVNL-UHFFFAOYSA-N; [M+FA-H]-; CNP0441303
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.638; IATZHJGSCGLJSL-HGXVMFPFNA-N; [M+FA-H]-; UNPD74344
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.627; KWOJRUXATGLSHQ-UHFFFAOYSA-N; [M+FA-H]-; N,N,1,2-tetramethylcyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.623; BVUWSAIHNBMOAG-UHFFFAOYSA-N; [M+FA-H]-; 2-propyl-2,3,4,5-tetrahydropyridin-5-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.616; XKFPNHDGLSYZRC-SSDOTTSWSA-N; [M+FA-H]-; (3r)-1-Acetyl-3-Methylpiperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.616; BNXZHVUCNYMNOS-UHFFFAOYSA-N; [M+FA-H]-; 1-butylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.616; YAZVALIFWKLNDA-UHFFFAOYSA-N; [M+FA-H]-; CNP0449343
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.592; NFPDMQSJCHCCKU-UHFFFAOYSA-N; [M+FA-H]-; N-(1-cyclohexylethylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GUAHPAJOXVYFON-UHFFFAOYNA-N; [M-H]-; Polyethylene glycol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VBZVQWDDUOUQHA-UHFFFAOYSA-N; [M-H]-; UNPD76707
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FDOBDBWYWMTMKT-UHFFFAOYNA-N; [M+FA-H]-; Conhydrinone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JEIZLWNUBXHADF-SVGMAFHSNA-N; [M+FA-H]-; (R)-Pelletierine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; HHEXLXPVRAJVIS-FPLPWBNLSA-N; [M+FA-H]-; UNPD196130
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.999; OCHUGKAFISDSCN-UHFFFAOYSA-N; [M+FA-H]-; 6-methyl-5-(propan-2-yl)-3,4-dihydro-2H-oxazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.978; HINLFAQOKAHXOD-UHFFFAOYSA-N; [M+FA-H]-; 2-propan-2-ylpent-4-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.974; RPALEGQGCGCFCX-FIWMUJSFSA-N; [M-H]-; (E)-2-Butenyl-4-methyl-threonine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.888; NPDKTSLVWGFPQG-UHFFFAOYNA-N; [M-H]-; (3R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.885; JLFAFRJZNUBKDM-UHFFFAOYSA-N; [M+FA-H]-; 2,2,3,3-tetramethylcyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.403; KWOJRUXATGLSHQ-UHFFFAOYSA-N; [M+FA-H]-; N,N,1,2-tetramethylcyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.395; CLZYHHJDMWJIKU-UHFFFAOYSA-N; [M-H]-; 6-methyl-4-(methylamino)-5-oxoheptanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.383; RNFCYFVPNIXAHP-UHFFFAOYSA-N; [M-H]-; N-Heptanoylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.351; CLKPVQZFNYXFCY-UHFFFAOYSA-N; [M-H]-; 1-hydroxy-2,2,5,5-tetramethylpyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.343; ADKXZIOQKHHDNQ-SVGMAFHSNA-N; [M+FA-H]-; (+)-Hygrine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.340; SMAUMNRVOPPBNC-JLDDOWRYNA-N; [M+FA-H]-; (+)-Physoperuvine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.340; TZEMYNIWYNDOLG-JLDDOWRYNA-N; [M+FA-H]-; UNPD173371
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.314; BKWVNPXVPQOROM-MBPFSUDVNA-N; [M+FA-H]-; Physoperuvine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.314; CYHOMWAPJJPNMW-INTDOSGANA-N; [M+FA-H]-; Pseudotropine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.314; VJPHAMJNGICSLT-UHFFFAOYSA-N; [M+FA-H]-; UNPD53487
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.307; BVUWSAIHNBMOAG-UHFFFAOYSA-N; [M+FA-H]-; 2-propyl-2,3,4,5-tetrahydropyridin-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.305; SRPNQDXRVRCTNK-UHFFFAOYSA-N; [M-H]-; pivagabine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.299; PGMBNUMLNAJSJR-CFQLRCIDNA-N; [M+FA-H]-; UNPD24103
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.297; WEFZXWJJPHGTTN-UHFFFAOYNA-N; [M-H]-; methyl 5-(dimethylamino)-2-methyl-5-oxopentanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.295; YAZVALIFWKLNDA-UHFFFAOYSA-N; [M+FA-H]-; CNP0449343
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.278; JKTAZDIARLXYPE-MQWKRIRWSA-N; [M-H]-; (2S)-2-(2-hydroxybut-3-enylamino)-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.278; UKWXGBZWYMGFTJ-MQWKRIRWSA-N; [M-H]-; (2S)-2-(1-hydroxybut-3-en-2-ylamino)-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.276; AGLLYYHKZWZSKX-VQZIKBDANA-N; [M-H]-; Hyacinthacine A3;(1R,2R,3R,5R,7aR)-1,2-Dihydroxy-3-hydroxymethyl-5-methylpyrrolizidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.233; LOFDEIYZIAVXHE-YUMQZZPRSA-N; [M+FA-H]-; Trachelanthamidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.233; IATZHJGSCGLJSL-HGXVMFPFNA-N; [M+FA-H]-; UNPD74344
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.233; PGGCTNQYCZTVNL-UHFFFAOYSA-N; [M+FA-H]-; CNP0441303
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.226; RAAWJSCIRLJCEG-UHFFFAOYSA-N; [M-H]-; 4-methylmorpholin-2-yl 2-methylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.215; FKJHJSJBXISMIR-UHFFFAOYSA-N; [M+FA-H]-; 1-(1-Pyrrolidinyl)-2-butanone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.215; IXYTUYCLJBLYKD-UHFFFAOYNA-N; [M+FA-H]-; 3-(1-Pyrrolidinyl)-2-butanone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.215; XKFPNHDGLSYZRC-SSDOTTSWSA-N; [M+FA-H]-; (3r)-1-Acetyl-3-Methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.215; ACGZBRWTWOZSFU-UHFFFAOYSA-N; [M+FA-H]-; 4-(diethylamino)-2-butyn-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.215; BNXZHVUCNYMNOS-UHFFFAOYSA-N; [M+FA-H]-; 1-butylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.215; UUTIAUFCXVFAOM-HJWRWDBZSA-N; [M+FA-H]-; UNPD131274
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.215; NFPDMQSJCHCCKU-UHFFFAOYSA-N; [M+FA-H]-; N-(1-cyclohexylethylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.215; XKJCOKCJVCRUCC-UHFFFAOYSA-N; [M+FA-H]-; 4-(tert-butylamino)but-3-en-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; GUAHPAJOXVYFON-UHFFFAOYSA-N; [M-H]-; 8-amino-7-oxononanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.552; CYHOMWAPJJPNMW-DHBOJHSNSA-N; [M+FA-H]-; (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.144; SRPNQDXRVRCTNK-UHFFFAOYSA-N; [M-H]-; 4-(2,2-dimethylpropanoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.893; HINLFAQOKAHXOD-UHFFFAOYSA-N; [M+FA-H]-; 2-propan-2-ylpent-4-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.360; BNXZHVUCNYMNOS-UHFFFAOYSA-N; [M+FA-H]-; 1-butylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.354; JEIZLWNUBXHADF-UHFFFAOYSA-N; [M+FA-H]-; 1-piperidin-2-ylpropan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.325; JMCVCHBBHPFWBF-UHFFFAOYSA-N; [M+FA-H]-; N,N-diethyl-2-methylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.322; APCBTRDHCDOPNY-SSDOTTSWSA-N; [M-H]-; tert-butyl (3R)-3-hydroxypyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.245; MFSGRTBIYFKOKF-UHFFFAOYSA-N; [M-H]-; 2-(aminomethyl)-3-(oxan-4-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; YDLSUFFXJYEVHW-UHFFFAOYSA-N; [M+FA-H]-; azonan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.205; DKLQJNUJPSHYQG-UHFFFAOYSA-N; [M+FA-H]-; 2-cyclohexylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.183; NPDKTSLVWGFPQG-SSDOTTSWSA-N; [M-H]-; (3R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; VMEZWHAEQCFDKW-UHFFFAOYSA-N; [M+FA-H]-; 2-(2-oxabicyclo[3.1.1]heptan-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.155; LXIKBPIUPDQDBK-QMMMGPOBSA-N; [M-H]-; (3S)-3-(formamidomethyl)-5-methylhexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.142; UVSCMYBDMIBAFY-UHFFFAOYSA-N; [M+FA-H]-; 1-(1-aminocyclopentyl)propan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.141; TVZCMRAQKHFNRF-UHFFFAOYSA-N; [M+FA-H]-; (4-ethyl-2-oxabicyclo[2.1.1]hexan-1-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.140; QHOGDAIMTBASPN-UHFFFAOYSA-N; [M+FA-H]-; 1-(3-aminocyclohexyl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; GBWNJTMOJAPZPQ-UHFFFAOYSA-N; [M+FA-H]-; 2-cyclopropyl-3-methyloxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; MDVOVTXBILKUPX-UHFFFAOYSA-N; [M+FA-H]-; (4-methyl-2-oxabicyclo[2.2.1]heptan-1-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; MXKPKMTUXCUVOD-UHFFFAOYSA-N; [M+FA-H]-; (3,3-dimethyl-2-oxabicyclo[2.1.1]hexan-1-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; KONQFMNFJCTDCY-UHFFFAOYSA-N; [M+FA-H]-; (5-methyl-2-oxabicyclo[3.1.1]heptan-1-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; NTOATGMWDDWCQB-UHFFFAOYSA-N; [M+FA-H]-; (4-methyl-7-oxabicyclo[2.2.1]heptan-1-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.137; MVPCVSWLCKMXFN-UHFFFAOYSA-N; [M-H]-; 3-amino-4-cyclopentyl-2-hydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.136; PTFYUPFXMGLEIK-UHFFFAOYSA-N; [M+FA-H]-; 3-methoxyspiro[3.3]heptan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.136; ZRWHDGCLKCQSAD-UHFFFAOYSA-N; [M+FA-H]-; 2-methoxyspiro[3.3]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.133; XOWRJAXBYGZUQY-UHFFFAOYSA-N; [M+FA-H]-; 4-aminobicyclo[2.2.2]octan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.133; RQDNTWYRVSVNSZ-UHFFFAOYSA-N; [M+FA-H]-; 1-(1-aminocyclohexyl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.131; JLVUAMOZHBDOTJ-UHFFFAOYSA-N; [M+FA-H]-; 1-methyl-2-oxabicyclo[2.2.2]octan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; AVWJZIGTXFPFFZ-UHFFFAOYSA-N; [M+FA-H]-; 4-prop-2-enyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; ARQNRYRGUMKTJV-UHFFFAOYSA-N; [M+FA-H]-; 2-oxaspiro[3.5]nonan-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; LTYSMVXAJZQBNP-UHFFFAOYSA-N; [M+FA-H]-; 1-oxaspiro[4.4]nonan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.129; NLUJOWHCPACBPT-UHFFFAOYSA-N; [M+FA-H]-; 1-oxaspiro[4.4]nonan-9-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; RMVLBZZOXGVWJU-UHFFFAOYSA-N; [M+FA-H]-; 5-oxaspiro[3.5]nonan-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; JPPOHCIGCIBQAB-UHFFFAOYSA-N; [M+FA-H]-; 1-oxaspiro[3.5]nonan-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; IGHMPJLCFPTLSY-UHFFFAOYSA-N; [M+FA-H]-; 2-amino-1-cyclohexylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; AGYDBYLANJUDTN-UHFFFAOYSA-N; [M+FA-H]-; (2-aminospiro[3.3]heptan-6-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; DJZUXFDAFKPNFI-UHFFFAOYSA-N; [M+FA-H]-; 7-oxaspiro[3.5]nonan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; OKKSVCPRNITCFK-UHFFFAOYSA-N; [M+FA-H]-; 6-oxaspiro[3.5]nonan-9-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; BJRYPSJURUNWQK-UHFFFAOYSA-N; [M+FA-H]-; 1-(methoxymethyl)cyclohex-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; MOTXTPXYTRYOSD-UHFFFAOYSA-N; [M+FA-H]-; 7-methoxybicyclo[3.2.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; UBWACJKDDJAVEI-UHFFFAOYSA-N; [M+FA-H]-; 1-(1-methoxycyclobutyl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; YNTJGZBUFFVLPV-UHFFFAOYSA-N; [M+FA-H]-; 8-oxabicyclo[3.2.1]octan-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; ZDTIUHUGDCJDRO-UHFFFAOYSA-N; [M+FA-H]-; 7-oxaspiro[3.5]nonan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; KDGDKBOVCNEWPO-UHFFFAOYSA-N; [M+FA-H]-; 5-oxaspiro[3.5]nonan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; AZHAYPBYLOQJFW-UHFFFAOYSA-N; [M+FA-H]-; 6-oxaspiro[2.5]octan-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; QZJZYADKOJRBIX-UHFFFAOYSA-N; [M+FA-H]-; 2-cyclopropyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; RPBKHWWRNPJZLF-UHFFFAOYSA-N; [M+FA-H]-; 2,3,3a,4,5,6,7,7a-octahydro-1-benzofuran-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; IQWZKMSEVNNCCC-UHFFFAOYSA-N; [M+FA-H]-; 2,3,3a,4,5,6,7,7a-octahydro-1-benzofuran-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; BGYRPUGBZRCIOG-UHFFFAOYSA-N; [M+FA-H]-; 6-(aminomethyl)spiro[3.3]heptan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; WQUXLLOXLHVXLX-UHFFFAOYSA-N; [M+FA-H]-; 1-oxaspiro[4.4]nonan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; GZTPNMLFIXIZPZ-BWWPFHEWSA-N; [M+FA-H]-; [(1S,5S)-6-amino-3-bicyclo[3.2.0]heptanyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; WGZQUMKILJKQKQ-OOJXKGFFSA-N; [M+FA-H]-; [(1R,2R,4R,5R)-5-amino-2-bicyclo[2.2.1]heptanyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; PBXGADKSTZKJJF-RNJXMRFFSA-N; [M+FA-H]-; [(1R,2R,4R)-2-amino-1-bicyclo[2.2.1]heptanyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; NDHCLIXZIAMFAE-UHFFFAOYSA-N; [M+FA-H]-; 5-oxaspiro[3.5]nonan-9-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; HTGCXYZBINTCIH-UHFFFAOYSA-N; [M+FA-H]-; 6-oxaspiro[3.4]octan-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; OJQPYDJEZANHMX-UHFFFAOYSA-N; [M+FA-H]-; 6-aminobicyclo[2.2.2]octan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; IGFFNPSUQAREPD-UHFFFAOYSA-N; [M+FA-H]-; 3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]furan-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; YCGCLTUHAOEULF-UHFFFAOYSA-N; [M+FA-H]-; (5-cyclopropyloxolan-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; ISHVGXAOOZNXOA-CSMHCCOUSA-N; [M+FA-H]-; [(1S,2R,5R)-3-oxabicyclo[3.2.1]octan-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; HHAJRVKFKZSUGW-UHFFFAOYSA-N; [M+FA-H]-; 2-oxabicyclo[2.2.2]octan-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.123; FXUQQEAOOMSXHG-UHFFFAOYSA-N; [M+FA-H]-; 1-(oxan-4-yl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.122; FNTGZSVSOXZCJE-UHFFFAOYSA-N; [M+FA-H]-; 2-amino-1,1-dicyclopropylethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.121; LVLXRKVTJBYFPI-UHFFFAOYSA-N; [M+FA-H]-; 2-(oxan-4-yl)prop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; QGMMKSUHQMVLRO-UHFFFAOYSA-N; [M+FA-H]-; (3-amino-2-bicyclo[2.2.1]heptanyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; FCOCJUKIMLOQMP-UHFFFAOYSA-N; [M+FA-H]-; (2-aminospiro[3.3]heptan-2-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; FFOVFEXQFJSIFV-UHFFFAOYSA-N; [M+FA-H]-; 2-oxabicyclo[2.2.2]octan-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; QUYZHMCGAIUVBQ-UHFFFAOYSA-N; [M+FA-H]-; (4-amino-1-bicyclo[2.2.1]heptanyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; TUZMYLBFTSJCDZ-UHFFFAOYSA-N; [M+FA-H]-; [5-(aminomethyl)spiro[2.3]hexan-5-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; OOZDMPVHNNWODG-UHFFFAOYSA-N; [M+FA-H]-; 1-amino-3-cyclopentylpropan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; LPDIAYLVZDAPJD-UHFFFAOYSA-N; [M+FA-H]-; 1-(oxan-3-yl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; KAZBZSJVGLDZTH-UHFFFAOYSA-N; [M+FA-H]-; 4-cyclopropyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; CWMLBSIBQJDFJN-UHFFFAOYSA-N; [M+FA-H]-; [2-(aminomethyl)spiro[2.3]hexan-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; XNVBUZNZIZXLRH-HTQZYQBOSA-N; [M+FA-H]-; [(3aR,6aR)-2,3,4,5,6,6a-hexahydrocyclopenta[b]furan-3a-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; HAAAFWGJLNDFLI-UHFFFAOYSA-N; [M+FA-H]-; (2-cyclopropyloxolan-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; IKVQJSYMPFEWBF-UHFFFAOYSA-N; [M+FA-H]-; 2-oxabicyclo[2.2.2]octan-1-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; OEYJFLZBZSJRBT-RNJXMRFFSA-N; [M+FA-H]-; (1R,2R,4S)-2-(aminomethyl)bicyclo[2.2.1]heptan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; BVPIHHVATRMZOT-UHFFFAOYSA-N; [M+FA-H]-; 6-oxabicyclo[3.2.1]octan-5-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; VSAMTOREUSCWJH-UHFFFAOYSA-N; [M+FA-H]-; 3,4,5,6,7,7a-hexahydro-2H-1-benzofuran-3a-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; IQTHHXUUFOWKED-JGVFFNPUSA-N; [M+FA-H]-; [(3aS,6aS)-2,3,3a,4,5,6-hexahydrocyclopenta[b]furan-6a-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.118; CSIDCRITTPQUBG-UHFFFAOYSA-N; [M+FA-H]-; [3-(aminomethyl)-3-bicyclo[3.1.0]hexanyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.118; LTKGCNKEONYLRE-UHFFFAOYSA-N; [M+FA-H]-; [1-(aminomethyl)-2-bicyclo[2.1.1]hexanyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.116; FCALZFOTXMVUTL-UHFFFAOYSA-N; [M+FA-H]-; 1,3,3-trimethyl-2-oxabicyclo[2.1.1]hexan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; KHLMBHAHHYQEFE-UHFFFAOYSA-N; [M+FA-H]-; 3-(2-methoxyethyl)bicyclo[1.1.1]pentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.112; BQOUKOFSUDJODA-UHFFFAOYSA-N; [M-H]-; 2-carbamoyl-3-methyl-2-propan-2-ylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.072; FDOBDBWYWMTMKT-UHFFFAOYSA-N; [M+FA-H]-; 1-piperidin-2-ylpropan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; UUBQFNWSTBBPSP-UHFFFAOYSA-N; [M+FA-H]-; 1-(1-bicyclo[1.1.1]pentanyl)-2-methoxyethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.024; XTQZONYRNXFGCY-RQJHMYQMSA-N; [M-H]-; (2S,4R)-4-[(2-methylpropan-2-yl)oxy]pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.009; QQZXAODFGRZKJT-UHFFFAOYSA-N; [M+FA-H]-; N-tert-butyl-2-methylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; ADKXZIOQKHHDNQ-MRVPVSSYSA-N; [M+FA-H]-; 1-[(2R)-1-methylpyrrolidin-2-yl]propan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.960; KVYOWXUQJLOCIA-UHFFFAOYSA-N; [M+FA-H]-; 1-oxa-8-azaspiro[4.5]decane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.932; OXXXNXISRXFPBK-UHFFFAOYSA-N; [M+FA-H]-; 2-oxa-8-azaspiro[4.5]decane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; LLMKXWOGGBBSTI-UHFFFAOYSA-N; [M+FA-H]-; 1-piperidin-3-ylpropan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.901; VRPSWZFSCOVZGF-UHFFFAOYSA-N; [M+FA-H]-; 2-methyl-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[b]pyrrol-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.901; IGJIOQMLMGKGHA-UHFFFAOYSA-N; [M+FA-H]-; 6,6-dimethylazepan-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; ADDYLHAEIGUETQ-UHFFFAOYSA-N; [M+FA-H]-; 2-cyclopropyl-2-methylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; JYWQUNJJKAOYAR-UHFFFAOYSA-N; [M+FA-H]-; 3-cyclopropyl-3-methylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; RNKRUMKDAJVRSL-UHFFFAOYSA-N; [M+FA-H]-; 2-cyclopropyl-6-methylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; GVFWFJBFIIIDFW-UHFFFAOYSA-N; [M+FA-H]-; 6-methyl-5-oxa-8-azaspiro[3.5]nonane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; JVBOTGLQUHBBCV-UHFFFAOYSA-N; [M+FA-H]-; 8-oxa-2-azaspiro[4.5]decane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; CSLIDOLMRRXRSF-OCAPTIKFSA-N; [M+FA-H]-; (3aR,6aS)-3a,6a-dimethyl-3,4,5,6-tetrahydro-1H-furo[3,4-c]pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; WLDJNAPPDGAIND-UHFFFAOYSA-N; [M+FA-H]-; (5-methyl-3-azabicyclo[3.1.1]heptan-1-yl)methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -38.687; GUAHPAJOXVYFON; [M-H]-; 8-amino-7-oxononanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -72.344; VBZVQWDDUOUQHA; [M-H]-; 9-amino-8-oxononanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -160.716; NPDKTSLVWGFPQG; [M-H]-; 3-iso-butyl-glutaric acid monoamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.425; TWFYCPDKEVVTJF; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -217.201; RNFCYFVPNIXAHP; [M-H]-; N-Heptanoylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -220.636; RPALEGQGCGCFCX; [M-H]-; 2-Butenyl-4-methyl-L-threonine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -231.835; SRPNQDXRVRCTNK; [M-H]-; Pivagabine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.613; CLZYHHJDMWJIKU; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.505; DACCNNJQBLQJBR; [M-H]-; Allyl N-(5-hydroxypentyl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.486; BQOUKOFSUDJODA; [M-H]-; Malonamic acid, 2,2-diisopropyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.386; HTBNREYQOZPEQT; [M-H]-; Carbamic acid, (2-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -295.397; BMOZRIPGPNWTIO; [M-H]-; methyl 3-(4-hydroxypiperidin-1-yl)propanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -295.682; UFPOXIDCAFAGCW; [M-H]-; ethyl 2-(3-hydroxypiperidin-1-yl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.114; AGLLYYHKZWZSKX; [M-H]-; Hyacinthacine A4
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.989; GCHHDBCXGJEKER; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.811; KGDDIHUWJWGQDG; [M-H]-; Methyl 2-methyl-3-morpholinopropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -306.874; WRBIQTVRBWJCQT; [M-H]-; Oprea1_204981
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.267; UDPXIIWXAUGKLP; [M-H]-; ethyl 2-(4-hydroxypiperidin-1-yl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.291; OSQKYXSDUMJDCJ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -312.253; CLKPVQZFNYXFCY; [M-H]-; Oprea1_453832
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.283; VMVAZNHAQXIGMP; [M-H]-; tert-butyl N-[(1-oxidanylcyclopropyl)methyl]carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -337.148; WEFZXWJJPHGTTN; [M-H]-; Rhodiasolv Polarclean
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -339.884; GAPVPIADZVYYRO; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -348.319; QMOQPVUFPHQBEA; [M-H]-; 4-22-00-02070 (Beilstein Handbook Reference)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -348.542; WSUMHFNEPOYLJM; [M-H]-; cis-3-(Boc-amino)-cyclobutanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -349.903; HXRDRJKAEYHOBB; [M-H]-; Boc-Azetidin-3-ylmethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -351.480; JXLSDCIHYQAXOA; [M-H]-; tert-butyl2-formylpropan-2-ylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -356.335; APCBTRDHCDOPNY; [M-H]-; s-bochp
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -362.318; RIRQNBQBGSVENV; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -362.851; PXTUQQILCNMBLU; [M-H]-; 2-(4,4-Ethylenedioxypiperidino)ethenol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -414.615; SSNCISRVGSERBZ; [M-H]-; [(E)-4-ethoxy-4-hydroxy-2-oxobut-3-enyl]-trimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -419.898; QWOLDMMSVJDUIF; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -434.735; KFBVRHIVYDGZDU; [M-H]-; [3-(dimethylamino)oxan-2-yl] acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -447.223; RAAWJSCIRLJCEG; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -460.024; LKTQNKMBWIWRHC; [M-H]-; (2-hydroxy-3-prop-2-enoyloxypropyl)-trimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -481.277; CFQZTJPGSPUSSN; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.330; GUAHPAJOXVYFON; [M-H]-; 8-amino-7-oxononanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.522; GUAHPAJOXVYFON; [M-H]-; 8-amino-7-oxononanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -121.925; VBZVQWDDUOUQHA; [M-H]-; 9-amino-8-oxononanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -286.165; RNFCYFVPNIXAHP; [M-H]-; 2-heptanamidoacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -287.720; NPDKTSLVWGFPQG; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -297.141; DACCNNJQBLQJBR; [M-H]-; 5-(Allyloxycarbonylamino)-1-pentanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -306.363; AHHZPWICVXDGGE; [M-H]-; 2-(Heptylamino)-2-oxoacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -307.681; JXLSDCIHYQAXOA; [M-H]-; tert-Butyl (2-methyl-1-oxopropan-2-yl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -313.774; VOOJKEYWUQROJS; [M-H]-; ethyl N-cyclopropyl-O-methylserinate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -314.491; QMGQOBFOCKWQDP; [M-H]-; Tert-butyl 3-(aminomethyl)oxetane-3-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -317.009; SRPNQDXRVRCTNK; [M-H]-; 4-(2,2-Dimethylpropanoylamino)butanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.147; GUAHPAJOXVYFON; [M-H]-; 8-amino-7-oxononanoic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C9H16N1O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 5.422
MS$FOCUSED_ION: PRECURSOR_M/Z 186.113069
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-004r-0900000000-7be80d8c9b704754a430
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  97.0644747 113.6416 97.064483 1.2157 15.81 0.9792 21 ?
  97.9137808 48.8666 97.913791 1.0213 20.85 -0.0956 17 ?
  99.9243633 147.3593 99.924376 1.2509 44.60 0.6951 22 ?
  111.8931544 67.9186 111.893186 1.2959 30.82 -0.1169 21 ?
  115.9192868 65.3876 115.919326 1.2164 24.72 0.3868 22 ?
  116.9273267 202.6626 116.927368 1.3342 82.52 -0.0740 22 ?
  123.0801300 63.3151 123.080183 1.3975 13.24 0.9070 19 ?
  125.0958708 999.0000 125.095928 0.6555 0.00 0.9706 22 ?
  126.0992316 80.5186 126.099291 1.2530 15.54 0.9263 19 ?
  127.8882124 112.4337 127.888276 1.2746 44.93 0.2947 19 ?
  130.9210351 54.2426 130.921105 1.4818 24.12 0.0333 19 ?
  132.9165408 82.1442 132.916616 1.1210 34.98 0.0060 20 ?
  138.8895820 65.7812 138.889671 1.5840 30.15 -0.1723 18 ?
  142.1224689 56.8704 142.122566 1.0202 12.98 0.8163 18 f{C8H16N1O1}/-8.93ppm,p-C1O2
  142.8969871 69.0968 142.897086 1.1197 32.70 -0.0632 19 ?
  143.8977908 99.4714 143.897893 1.2787 39.89 0.3825 19 ?
  156.8936758 115.7514 156.893814 1.5552 45.28 0.5000 16 ?
  158.8920947 85.4549 158.892239 1.3972 29.37 0.4208 21 ?
  159.8929026 131.8868 159.893049 0.9131 48.56 0.2053 19 ?
  186.1127163 737.2789 186.112787 0.4997 63.12 1.0000 22 f{C9H16N1O3}/-4.57ppm,p
  187.1164372 74.3684 187.116429 1.5124 20.30 0.7812 18 ?
PK$NUM_PEAK: 21
PK$PEAK: m/z int. rel.int.
  97.064475 113.64 113
  97.913781 48.87 48
  99.924363 147.36 147
  111.893154 67.92 67
  115.919287 65.39 65
  116.927327 202.66 202
  123.080130 63.32 63
  125.095871 999.00 999
  126.099232 80.52 80
  127.888212 112.43 112
  130.921035 54.24 54
  132.916541 82.14 82
  138.889582 65.78 65
  142.122469 56.87 56
  142.896987 69.10 69
  143.897791 99.47 99
  156.893676 115.75 115
  158.892095 85.45 85
  159.892903 131.89 131
  186.112716 737.28 737
  187.116437 74.37 74
//
